ATP competitive MEK1 inhibitors (Merck Research Laboratories)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameATP competitive MEK1 inhibitors (Merck Research Laboratories)
Drug Alias NameSCH-1514874SCH-1476641SCH-1515998SCH-1518307
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsDual specificity mitogen-activated protein kinase kinase 1 inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A